LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,336 pages found matching General Motors- Makers of Zyprexa Risperdal and Seroquel Under Fire
Mar-9-07 Washington, DC: Eli Lilly, Johnson & Johnson, and AstraZeneca, are all named defendants in a new lawsuit filed by the state of Pennsylvania on February 26, 2007, to recover money paid through public health care programs to purchase Zyprexa , Risperdal, and Seroquel, and the costs of medical care for the people injured by these drugs. Pennsylvania... - Stockbroker Arbitration: When Class Action Lawsuits are Best
Mar-9-07 New York, NY: For cases in which individual investors have grievances with their stockbrokers, investors usually find that stockbroker arbitration is the best course of action. In fact, if an investor has signed an agreement to submit to arbitration he has no choice and must take his claim to arbitration. However, when there are large groups of inves... - Depakote linked to Serious Birth Defects and Death
Mar-8-07 Abbot Park, IL: A study released last year has shown that the effects of Depakote can be devastating for newborns exposed to the drug before birth. The study, released in the August 8, 2006 issue of Neurology, found that major congenital malformations and fetal death were more common for women who took Depakote while pregnant compared with women who took... - American International Group Inc. Accounting and Sales Settlement
New York, NY: (Mar-01-07) A probe begun by former New York Attorney General Eliot Spitzer, the US Securities and Exchange Commission, and the Justice Department against American International Group Inc., claimed that AIG restated earnings twice. In doing so, the company lowered net income for 2000 to 2005 by $3.4 billion, cheated workers compensation progr... - Behind the Scenes Snake Oil Salesmen
Mar-7-07 Washington, DC: While the pharmaceutical industry's corrupt practice of peddling ineffective drugs and concealing dangerous side effects has come under scrutiny in recent years, critics say the contributions of the research scientists, academics, medical journals, and the FDA deserve far more credit for their part in the industry's overall marketing scheme... - FDA - The Rest of the Story
Mar-7-07 Washington, DC: The 12,000-employee FDA regulates products that account for more than $1.5 trillion in yearly sales, or about a 10th of the US economy. Besides food and drug safety, the agency also enforces regulations covering medical devices and cosmetics. The FDA is part of the executive branch of government and therefore, any filing of reports by co... - Veterans Affairs a National Failure
Mar-6-07 Washington, DC: Walter Reed Medical Center may not be a Veterans Affairs (VA) center but problems at the hospital highlight the treatment that some veterans receive when they return home from active duty, including medical malpractice, poor living conditions and lost files. Unfortunately, the recent problems at Walter Reed Medical Center are not new b... - Suicide Risk of Neurontin Kept Hidden for Years
Feb-27-07 Washington, DC: Neurontin , the all-time poster child for an illegally promoted off-label drug, was marketed by Warner-Lambert and its Parke-Davis division until Pfizer acquired the company in 2000. The term "off-label" means prescribing a drug for indications not listed on the label, upping the recommended dose, prescribing a drug in combination with... - Did SSRI Meds cause my Son's Birth Defects?
Feb-26-07 Salt Lake City, UT Trudy Hanson is sitting in a waiting room at Primary Children's Hospital, a room that has become her second home since giving birth to her son - this is Michael's 14th surgery. Trudy says she can't help but blame herself for taking Effexor while she was pregnant. "I started taking Effexor a few months before I was pregnant and cont... - State Farm Policyholders Coverage Settlement
Biloxi, MS: (Feb-18-07) Following a pattern set in Florida, Mississippi Attorney General Jim Hood is seeking legislation that will block insurance companies from refusing to write new homeowners and commercial policies in hurricane hit states. The move was spurred by State Farm's new policies stemming out of the inhospitable climate in the state. Hood s... - Investigations Target SSRI Prescribing Doctors
Feb-23-07 Washington, DC: In recent years, Federal and state investigators have been going after the makers of the antidepressants known as the selective serotonin reuptake inhibitors (SSRI), for promoting the drugs for off-label use under the theory that they are causing the submission of false claims to Medicare, Medicaid, and other public health care programs... - Trail of Paxil Suicides Leads To GlaxoSmithKline
Feb-14-07 Washington, DC: On January 29, 2007, BBC-One broadcast, "Secrets of the Drug Trials," a Panorama program based on an investigation by reporter, Shelley Jofre, which revealed how GlaxoSmithKline misled doctors into prescribing Paxil off-label to children, even after its own clinical trials found that kids could become suicidal when taking the drug. The... - Corwith's Auto Body et al. North Sea Landfill Pollution Settlement
Southampton Town, NY: (Feb-07-07) A settlement has been reached today by 29 businesses and government entities with the New York State attorney general's office over the cost of cleanup at the old North Sea landfill in Southampton Town. The defendants included, Corwith's Auto Body , Hampton Jitney, Colossal Carting Co., Kraft Foods Global, MTA, Long Is... - Fosamax - Dental Professionals Concerned about ONJ
Feb-12-07 Denver, CO: Fosamax , made by Merck, was approved to help people suffering from Osteoporosis, a disease in which people lose bone mass and density which can result in bones that break easily. However, many people who have taken Fosamax have reported another problem, Osteonecrosis of the Jaw (ONJ). It was around five years ago that dentists and oral sur... - MBIA Inc. Securities Fraud Bond Settlement
Armonk, NY: New York State and federal regulators filed a securities fraud and misuse of finite reinsurance lawsuit against MBIA Inc. The investigations into the financial guarantee insurer alleged use of sham reinsurance transactions in 1998 to mask a $170 million bond loss incurred on its guarantee of bonds issued by a bankrupt unit of Allegheny Healt... - Carolina Tobacco Company Oregon Registration Settlement
Portland, OR: A lawsuit begun in 2003 that questioned Carolina Tobacco Company's (CTC) legal standing to submit Oregon certifications and make the escrow payments as required as a manufacturer under the Tobacco Master Settlement Agreement. The issue branched out into several different lawsuits. Carolina Tobacco Company announced two settlement agreement... - Off-Label Depakote Sales Stronger Than Ever
Feb-11-07 Washington, DC: The epilepsy drug, Depakote , earned Abbott Laboratories $384 million in the 4th quarter of 2006, and overall sales rose 18.5% to $1.2 billion last year. The rising sales are a result of Depakote (valproate) being increasingly prescribed for conditions other than epilepsy like mood disorders, manic depression and migraines. Doctors are... - Dr. Perry Hearn and Affiliated Professional Services, Inc. False Insurance Claims Settlement
Boston, MA: Norwell physician, Perry Hearn, and Affiliated Professional Services, Inc. (APS), based in Wareham, MA have agreed to pay $150,000 and $100,000 to settle allegations that they submitted false claims to the Medicare and Medicaid programs for office and nursing home visits performed by nurse practitioners and physician assistants without any p... - Consequences of Rampant Off-Label Prescribing of Depakote
Feb-7-07 Washington, DC: The antiepileptic drug, Depakote , is one of the most heavily prescribed medications for off-label use. The Epilepsy Foundation reports that there are an estimated 1 million women in the US with epilepsy, but the number of women being treated with antiepileptics is two to three times higher than the number of women with the disorder. Ex... - Healthcare Research and Development Institute Vendor Favoritism Settlement
Hartford, CT: State Attorney General Richard Blumenthal announced an antitrust settlement with Healthcare Research and Development Institute (HRDI), based in Pensacola, FL which was being investigated by Connecticut authorities. Blumenthal alleged that HRDI members showed favoritism to certain vendors, who paid $40,000 for membership privileges in the g...